Consultation with a general practitioner after cancer diagnosis
Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study
This study is testing whether having a follow-up consultation with a general practitioner after a cancer diagnosis can improve care for patients with solid tumors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 171 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut Claudius Regaud Academic / other |
| Locations | 4 sites (Auch and 3 other locations) |
| Trial ID | NCT06589414 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the feasibility of integrating a summary consultation with a general practitioner (GP) into the patient pathway following a cancer diagnosis. It will involve 171 patients with solid tumors who will be monitored for six months. The intervention follows the DAMeGe protocol, which organizes this summary consultation to enhance patient care and support. The study is multicentric and regional, focusing on patients treated in specific centers in the Occitanie region of France.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a solid tumor diagnosis who are receiving treatment at participating centers in the Occitanie region.
Not a fit: Patients who are currently involved in another clinical trial related to care pathways or those under legal protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve the coordination of care and support for cancer patients during a critical time in their treatment journey.
How similar studies have performed: While this specific approach is novel, similar studies focusing on enhanced communication and support in cancer care have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years. 2. Patient with a solid tumour whatever the organ. 3. Patient treated in one of the participating centres as part of a system for announcing the diagnosis of a solid cancer. 4. Patient undergoing cancer treatment in one of the participating centres. 5. Patient with a registered general practitioner in the Occitanie region. 6. Patient affiliated to a French Social Security scheme. 7. Patient having signed informed consent prior to inclusion in the study and prior to any specific procedure for the study. Exclusion Criteria: 1. Patient already included in another clinical trial concerning a care pathway. 2. Patient deprived of liberty or under legal protection (curatorship and guardianship, safeguard of justice). 3. Pregnant or breast-feeding woman.
Where this trial is running
Auch and 3 other locations
- CH Auch — Auch, France (Recruiting)
- CHU Larrey — Toulouse, France (Recruiting)
- CHU Rangueil — Toulouse, France (Recruiting)
- Institut Universitaire du Cancer de Toulouse - Oncopole — Toulouse, France (Recruiting)
Study contacts
- Study coordinator: Marie-Eve ROUGE BUGAT
- Email: Rouge.Marie-eve@iuct-oncopole.fr
- Phone: 05 31 15 51 22
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.